Close Menu

Imperial College London

By profiling metabolites in urine using NMR spectroscopy prior to drug exposure, a research group from Imperial College London and Pfizer found hints that may explain different responses to the painkiller acetominophen.

A study by the UK's Advanced Institute of Management Research claims that many companies find it increasingly difficult to partner with universities, despite recent efforts by the government to promote such collaboration. Study co-author Ammon Salter discussed the findings with BTW this week.

Mari Baker is leaving Navigenics, Andrew von Eschenbach has joined a consulting firm, Jay Flatley takes a seat on Helixis' board, and more.

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

Bioinformatics

Pages

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.